CytRx Corporation (NASDAQ:CYTR) disclosed in a filing that on March 14 CytRx entered into an amendment to that certain License Agreement, dated August 17, 2006 and amended on January 5, 2010, between the company and KTB Tumorgesellschaft GmbH. the company noted, “The License Agreement grants us a license to patent rights held by KTB for the worldwide development and commercialization of aldoxorubicin. The License Agreement also granted us an option to include within the license any technology that is claimed or disclosed in the licensed patents and patent applications for use in the field of oncology. CytRx Corporation (NASDAQ:CYTR) shares after opening at $4.31 on last trade day and at the end of the day closed at $4.08. Company price to sales ratio in past twelve months was calculated as 547.88 and price to cash ratio as 4.26. CytRx Corporation (NASDAQ:CYTR) showed a negative weekly performance of -20.00%.
MeetMe®, Inc. (NYSE MKT:MEET), the public market leader in social discovery, reported financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter 2013 Financial Highlights: Mobile average revenue per user (ARPU) exceeded web ARPU for the first time in Company history. In line with recently upwardly revised expectations, total revenue was $13.0 million, a 12% increase from the fourth quarter of 2012. Mobile revenue was up 128% from the year ago quarter to a record $5.1 million, driven primarily by a significant increase in mobile advertising. Mobile represented nearly 40% of total MeetMe fourth quarter revenue, the highest proportion in Company history. MeetMe Inc (NYSEMKT:MEET) shares advanced 0.29% in last trading session and ended the day on $3.43. MEET return on equity ratio is recorded as -15.60% and its return on assets is -13.20%. MeetMe Inc (NYSEMKT:MEET) yearly performance is 37.20%.
On February 18, 2014, Genco Shipping & Trading Limited (NYSE:GNK) and the other parties under that certain Loan Agreement, dated as of August 20, 2010, by and among the Company, the various lenders and other parties named therein, and Crédit Agricole Corporate and Investment Bank, as Agent and Security Trustee (the “$100 Million Term Loan Facility”), entered into a Limited Waiver of Default (the “Waiver Agreement”). Genco Shipping & Trading Limited (NYSE:GNK) shares moved up 1.39% in last trading session and was closed at $1.46, while trading in range of $1.33 – $1.48. Genco Shipping & Trading Limited (NYSE:GNK) year to date (YTD) performance is -41.60%.
Yongye International, Inc (NASDAQ:YONG), today announced its financial results for the fourth quarter and full year ended December 31, 2013. Full Year 2013 Financial Highlights: Revenue increased 49.4% to $661.9 million in 2013 from $443.0 million in 2012. Shipment of Yongye’s agricultural nutrient products increased 22.1% to $662.0 million in 2013 from $542.2 million in 2012, within the Company’s guidance of $650 to $680 million. Gross profit increased 54.3% year-over-year to $404.9 million. Net income attributable to Yongye increased 82.3% to $170.8 million, or $2.93 per diluted share, compared to $93.7 million, or $1.62 per diluted share, in the same period of 2012. Yongye International, Inc (NASDAQ:YONG) weekly performance is 787%. On last trading day company shares ended up $57. Yongye International, Inc (NASDAQ:YONG) distance from 50-day simple moving average (SMA50) is 757%. Analysts mean target price for the company is $89789.